Want to take quizzes and track your credits?
Most patients with severe degenerative mitral regurgitation (DMR) are likely to require surgery, but years can pass until there is a clear indication for it. The timing of mitral valve surgery for asymptomatic patients with severe DMR is controversial, and current guidelines are limited because they are based on nonrandomized studies and expert opinion.
In this narrative review, a decrease in left ventricular ejection fraction and an increase in left ventricular end-systolic diameter are adverse signs in the context of mitral regurgitation. Consequently, serial echocardiography is essential. However, measurements may be imprecise, and the evidence regarding the association with outcome in asymptomatic patients is inconsistent. Mitral valve repair is the preferred surgical approach; however, repair rate, durability, and outcomes vary between centers, rendering decision-making in an asymptomatic patient with DMR even more challenging. The use of natriuretic peptides, stress testing, cardiac magnetic resonance imaging, and myocardial strain imaging can aid in risk stratification and optimization of the timing of mitral valve surgery in an asymptomatic patient.
Conclusions and Relevance
Management of asymptomatic patients with DMR requires a comprehensive approach that goes beyond the guidelines. Close follow-up and the use of multiple modalities are recommended. Knowledge of surgical options, experience, and outcomes is important when an intervention is considered.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
Accepted for Publication: November 13, 2019.
Corresponding Author: Robert J. Siegel, MD, Smidt Heart Institute, Cedars-Sinai Medical Center, 127 S San Vicente Blvd, Room A3600, Los Angeles, CA 90048 (firstname.lastname@example.org).
Published Online: January 29, 2020. doi:10.1001/jamacardio.2019.5466
Author Contributions: Drs Flint and Siegel had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Flint, Raschpichler, Rader, Siegel.
Acquisition, analysis, or interpretation of data: Flint, Shmueli.
Drafting of the manuscript: Flint, Raschpichler, Siegel.
Critical revision of the manuscript for important intellectual content: Flint, Raschpichler, Rader, Shmueli.
Administrative, technical, or material support: Flint, Shmueli.
Supervision: Rader, Siegel.
Conflict of Interest Disclosures: Dr Rader reported receiving personal fees from ReCor Medical. No other disclosures were reported.
You currently have no searches saved.